European Heart Journal

European Heart Journal 2003 24(11):987-1003; doi:10.1016/S0195-668X(03)00114-3
Copyright © 2003 by the European Society of Cardiology.

This Article Abstract FREE Full Text (PDF) E-letters: Submit a response Alert me when this article is cited Alert me when E-letters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (591) Request Permissions Disclaimer Google Scholar Articles by Conroy, R.M. Search for Related Content PubMed PubMed Citation Articles by Conroy, R.M. Social Bookmarking          What's this?

Regular Articles

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

R.M. Conroy^a, K. Pyörälä^b, A.P. Fitzgerald^a, S. Sans^c, A. Menotti^d, G. De Backer^e, D. De Bacquer^e, P. Ducimetière^f, P. Jousilahti^g, U. Keil^h, I. Njølstadⁱ, R.G. Oganov^j, T. Thomsen^k, H. Tunstall-Pedoe^l, A. Tverdal^m, H. Wedelⁿ, P. Whincup^o, L. Wilhelmsenⁿ and I.M. Graham^a,* on behalf of the SCORE project group¹

^a Department of Epidemiology & Public Health Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland
^b University of Kuopio, Kuopio, Finland
^c Institute of Health Studies, The Catalan Department of Health and Social Security, Barcelona, Spain
^d Association for Cardiac Research, Rome, Italy
^e Department of Public Health, Ghent University, Ghent, Belgium
^f National Institute for Health and Medical Research (INSERM), Unit 258, Villejuif, France
^g Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland
^h Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
ⁱ Institute of Community Medicine, University of Tromsø, Tromsø, Norway
^j National Research Centre for Preventive Medicine, Russian Ministry of Health, Moscow, Russia
^k Centre for Preventive Medicine, Medical Department M, Glostrup University Hospital, Glostrup, Denmark
^l Cardiovascular Epidemiology Unit, Ninewells Hospital and Medical School, Dundee,Scotland, UK
^m Norwegian Institute of Public Health, Oslo, Norway
ⁿ Section of Preventive Cardiology, Göteborg University, Göteborg, Sweden
^o Department of Public Health Sciences, St. George's Hospital Medical School, London, UK

^* Corresponding author: Ian M. Graham (project leader), SCORE, Department of Epidemiology & Public Health Medicine, Royal College of Surgeons in Ireland, Dublin 2, Ireland. Tel.: +353-1-402-2434; fax: +353-1-402-2329
E-mail address: igraham{at}amnch.ie

	Abstract

Top Abstract 1. Introduction 2. Subjects and methods 3. Results 4. Discussion 5. Limitations Appendix A Appendix B: Project Structure... Footnotes  References

 
Aims The SCORE project was initiated to develop a risk scoring system for use in the clinical management of cardiovascular risk in European clinical practice.

Methods and results The project assembled a pool of datasets from 12 European cohort studies, mainly carried out in general population settings. There were 205 178 persons (88 080 women and 117 098 men) representing 2.7 million person years of follow-up. There were 7934 cardiovascular deaths, of which 5652 were deaths from coronary heart disease. Ten-year risk of fatal cardiovascular disease was calculated using a Weibull model in which age was used as a measure of exposure time to risk rather than as a risk factor. Separate estimation equations were calculated for coronary heart disease and for non-coronary cardiovascular disease. These were calculated for high-risk and low-risk regions of Europe. Two parallel estimation models were developed, one based on total cholesterol and the other on total cholesterol/HDL cholesterol ratio. The risk estimations are displayed graphically in simple risk charts. Predictive value of the risk charts was examined by applying them to persons aged 45–64; areas under ROC curves ranged from 0.71 to 0.84.

Conclusions The SCORE risk estimation system offers direct estimation of total fatal cardiovascular risk in a format suited to the constraints of clinical practice.

Key Words: Cardiovascular disease • Risk factors • Risk estimation • Europe

---

 

	Acknowledgments

 
The funding of the SCORE project by the European Union Biomed-2 programme (contract BMH4-98-3186) and the additional support from the Royal College of Surgeons of Ireland are gratefully acknowledged. We also gratefully acknowledge the funding of the original participating studies and the SCORE project by participating institutions anddifferent national funding organisations.

We would like to acknowledge the professional advice of Dr Robert Clarke (Oxford, UK), Prof Alun Evans (Belfast, UK), Dr Ed Korn (Bethesda, MD, US), Prof Daan Kromhout (Bilthoven, The Netherlands), Dr Sarah Lewington (Oxford, UK), Prof Dan McGee (Charleston, SC, US), and Dr Qing Qiao (Helsinki, Finland), and the energetic advocacy of Prof Philip Poole-Wilson (London, UK), the former President of the ESC, in the planning phase of the project.

The SCORE Project Steering Committee gratefully acknowledges the efficient work of the Administrative Secretary of the project, Ms Jane Ingham (London, UK) in organising the Steering Committee meetings and SCORE Project workshops.

	Footnotes

Top Abstract 1. Introduction 2. Subjects and methods 3. Results 4. Discussion 5. Limitations Appendix A Appendix B: Project Structure... Footnotes  References

 
^* The Weibull model is traditionally expressed in terms of =exp()

	References

Top Abstract 1. Introduction 2. Subjects and methods 3. Results 4. Discussion 5. Limitations Appendix A Appendix B: Project Structure... Footnotes  References

 

1. Pyörälä K, deBacker G, Graham I et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology European Atherosclerosis Society and European Society of Hypertension. Eur Heart J. 1994;15:1300–1331.[Free Full Text]
2. Grundy SM, Balady GJ, Criqui MH et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation. 1998;97:1876–1887.[Free Full Text]
3. Anonymous. Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Heart. 1998;80(Suppl 2):S1–29.[Free Full Text]
4. Robson J, Feder G. Predicting and reducing cardiovascular risk. Heart. 2001;85:487–488.[Free Full Text]
5. Pearson TA, Blair SN, Daniels SR et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388–391.[Free Full Text]
6. Wood DA, De Backer G, Faergeman O et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J. 1998;19:1434–1503.[Free Full Text]
7. Jackson R. Guidelines on preventing cardiovascular disease in clinical practice. BMJ. 2000;320:659–661.[Free Full Text]
8. Anderson KM, Wilson PW, Odell PM et al. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356–362.[Free Full Text]
9. Jackson R, Barham P, Bills J et al. Management of raised blood pressure in New Zealand: a discussion document. BMJ. 1993;307:107–110.[Abstract/Free Full Text]
10. D'Agostino RBS, Grundy S, Sullivan LM et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180–187.[Abstract/Free Full Text]
11. Haq IU, Ramsay LE, Yeo WW et al. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart. 1999;81:40–46.[Abstract/Free Full Text]
12. Pyörälä K. Assessment of coronary heart disease risk in populations with different levels of risk. Eur Heart J. 2000;21:348–350.[Free Full Text]
13. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J. 2000;21:365–370.[Abstract/Free Full Text]
14. Thomsen TF, McGee D, Davidsen M et al. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol. 2002;31:817–822.[Abstract/Free Full Text]
15. Hense HW, Schulte H, Löwel H et al. Framingham risk function overestimates risk of coronary heart disease inmen and women from Germany. Results from the MONICA Augsburg cohort and the PROCAM cohort. Eur Heart J. 2003;: In Press.
16. Dawber TR, Kannel W, Revotskie N et al. The epidemiology of coronary heart disease – the Framingham Enquiry. Proc Royal Soc Med. 1962;55:265–271.
17. D'Agostino RB, Russell MW, Huse DM et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000;139:272–281.[Web of Science][Medline]
18. Menotti A, Lanti M, Puddu PE et al. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart. 2000;84:238–244.[Abstract/Free Full Text]
19. Vartiainen E, Jousilahti P, Alfthan G et al. Cardiovascular risk factor changes in Finland 1972–1997. Int J Epidemiol. 2000;29:49–56.[Abstract/Free Full Text]
20. Anonymous. Collaborative US-USSR study on the prevalence of dyslipoproteinemias and ischemic heart disease in American and Soviet populations. Prepared by the US-USSR Steering Committee for Problem Area 1: the pathogenesis of atherosclerosis. Am J Cardiol. 1977;40:260–268.[CrossRef][Web of Science][Medline]
21. Bjartveit K, Foss OP, Gjervig T et al. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand Suppl. 1979;634:1–70.[Medline]
22. Njølstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation. 1996;93:450–456.[Abstract/Free Full Text]
23. Shaper AG, Pocock SJ, Walker M et al. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ. 1981;283:179–186.[Abstract/Free Full Text]
24. Tunstall-Pedoe H, Woodward M, Tavendale R et al. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ. 1997;315:722–729.[Abstract/Free Full Text]
25. Schroll M, Jorgensen T, Ingerslev J. The Glostrup Population Studies 1964–1992. Dan Med Bull. 1992;39:204–207.[Web of Science][Medline]
26. Wilhelmsen L, Berglund G, Elmfeldt D et al. The multifactor primary prevention trial in Göteborg Sweden. Eur Heart J. 1986;7:279–288.[Abstract/Free Full Text]
27. Anonymous. (The BIRNH Study Group). Regional differences in dietary habits, coronary risk factors and mortality rates in Belgium. 1. Design and methodology. Nutrition and health: an interuniversity study. Acta Cardiol. 1984;39:285–292.[Web of Science][Medline]
28. Keil U, Liese AD, Hense HW et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984–1992. Monitoring Trends and Determinants in Cardiovascular Diseases. Eur Heart J. 1984;19:1197–1207.
29. Anonymous. (The RIFLE Research Group). Presentation of the RIFLE project risk factors and life expectancy. Eur J Epidemiol. 1993;9:459–476.[Web of Science][Medline]
30. Ducimetière P, Richard JL, Cambien F et al. Coronary heart disease in middle-aged Frenchmen. Comparisons between Paris Prospective Study, Seven Countries Study and Pooling Project. Lancet. 1980;1:1346–1350.[Medline]
31. Sans Menéndez S, Tomás Abadal L, Domingo Salvany A et al. Estudio de prevención multifactorial de la cardiopatía isquémica. Intervención sobre factores de riesgo coronario en una población industrial. Resultados de los dos primeros años. Rev San Hig Públ. 1981;55:555–570.
32. Rodés A, Sans S, Balañá LL et al. Recruitment methods and differences in early late and non-respondents in the first MONICA-Catalonia population survey. Rev Epidemiol Sante Publique. 1990;38:447–453.[Web of Science][Medline]
33. Sans Menéndez S. Ensayo randomizado de prevenciónmultifactorial de la cardiopatía isquémica. PhD doctoral dissertation. Bellaterra: Publications of the Autonomous University of Barcelona. 1994..
34. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145:72–80.[Abstract/Free Full Text]
35. Weissler AM. A perspective on standardizing the predictive power of noninvasive cardiovascular tests by likelihood ratio computation: 2. Clinical applications. Mayo Clin Proc. 1999;74:1072–1087.[Abstract]
36. Lin LI-K. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255–268.[CrossRef][Web of Science][Medline]
37. Lin LI-K. A note on the concordance correlation coefficient. Biometrics. 2000;56:324–325.[CrossRef]
38. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J. 1997;18:1231–1248.[Free Full Text]
39. Dawber TR, Kannel WB, McNamara PM. The prediction of coronary heart disease. Moore SRJ. Transactions of the Association of Life Insurance Medical Directors of America, Seventy-Second Annual Meeting, October 16, 1963, New York City. New York: Recording & Statistical Company; 1964. p. 70–105.
40. Wilson PF, D'Agostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847.[Abstract/Free Full Text]
41. Grundy SM, Pasternak R, Greenland P et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100:1481–1492.[Free Full Text]
42. Anonymous. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421.[Free Full Text]
43. Anonymous. Treatment and prevention of coronary heart disease by cholesterol lowering therapy: Consensus cholesterol, second revision. [In Dutch] Utrecht: CBO, 1998..
44. Johannesson M. At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention? Eur Heart J. 2001;22:919–925.[Abstract/Free Full Text]
45. Marshall T, Rouse A. Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study. BMJ. 2002;325:197.[Abstract/Free Full Text]
46. Durrington PN, Prais H, Bhatnagar D et al. Indicationsfor cholesterol-lowering medication: comparison of risk-assessment methods. Lancet. 1999;353:278–281.[CrossRef][Web of Science][Medline]
47. Durrington PN, Prais H. Methods for the prediction of coronary heart disease risk. Heart. 2001;85:489–490.[Free Full Text]
48. Smith SCJ, Blair SN, Criqui MH et al. Preventing heart attack and death in patients with coronary disease. Circulation. 1995;92:2–4.
49. Wilhelmsen L, Pyörälä K, Wedel H et al. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment. Eur Heart J. 2001;22:1119–1127.[Abstract/Free Full Text]
50. Grover SA, Paquet S, Levinton C et al. Estimating the benefits of modifying risk factors of cardiovasculardisease: a comparison of primary vs. secondary prevention [published erratum appears in Arch Intern Med Jun 8;158(11):1228]. Arch Intern Med. 1998;158:655–662.[Abstract/Free Full Text]
51. Stamler J, Vaccaro O, Neaton JD et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434–444.[Abstract]
52. Adlerberth AM, Rosengren A, Wilhelmsen L. Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study. Diabetes Care. 1998;21:539–545.[Abstract]
53. Stevens RJ, Kothari V, Adler AI et al. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101:671–679.[Medline]
54. Anonymous. National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand. N Z Med J. 1996;109:224–231.[Web of Science][Medline]
55. Hingorani AD, Vallance P. A simple computer program for guiding management of cardiovascular risk factors and prescribing. BMJ. 1999;318:101–105.[Abstract/Free Full Text]
56. Zambanini A, Smith MR, Feher MD. Prediction of cardiovascular risk. Program is not suitable for diabetic patients. BMJ. 1999;318:1418 author reply 1419.[Free Full Text]
57. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–1197..
58. Anonymous. Report of a WHO consultation: definition, diagnosis and classification of diabetes mellitus. (WHO/NCD/NCS/99.2). Geneva: World Health Organization, 1999..
59. Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: the WHO MultinationalStudy of Vascular Disease in Diabetes. Diabetologia. 2001;44(Suppl 2):S54–S64.
60. Kothari V, Stevens RJ, Adler AI et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke. 2002;33:1776–1781.[Abstract/Free Full Text]

CiteULike    Connotea    Del.icio.us    What's this?

This article has been cited by other articles:

				M. Jontell and M. Glick Oral Health Care Professionals' Identification of Cardiovascular Disease Risk Among Patients in Private Dental Offices in Sweden J Am Dent Assoc, November 1, 2009; 140(11): 1385 - 1391. [Abstract] [Full Text] [PDF]

				A. A.W.A. van der Heijden, M. M. Ortegon, L. W. Niessen, G. Nijpels, and J. M. Dekker Prediction of Coronary Heart Disease Risk in a General, Pre-Diabetic, and Diabetic Population During 10 Years of Follow-up: Accuracy of the Framingham, SCORE, and UKPDS Risk Functions: The Hoorn Study Diabetes Care, November 1, 2009; 32(11): 2094 - 2098. [Abstract] [Full Text] [PDF]

				K. Tambalis, D. B. Panagiotakos, S. A. Kavouras, and L. S. Sidossis Responses of Blood Lipids to Aerobic, Resistance, and Combined Aerobic With Resistance Exercise Training: A Systematic Review of Current Evidence Angiology, October 1, 2009; 60(5): 614 - 632. [Abstract] [PDF]

				Chia Yook Chin and S. Pengal Cardiovascular Disease Risk in a Semirural Community in Malaysia Asia Pac J Public Health, October 1, 2009; 21(4): 410 - 420. [Abstract] [PDF]

				M. T. Cooney, A. L. Dudina, and I. M. Graham Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1209 - 1227. [Abstract] [Full Text] [PDF]

				R. F. Redberg, E. J. Benjamin, V. Bittner, L. T. Braun, D. C. Goff Jr, S. Havas, D. R. Labarthe, M. C. Limacher, D. M. Lloyd-Jones, S. Mora, et al. ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1364 - 1405. [Full Text] [PDF]

				WRITING COMMITTEE MEMBERS, R. F. Redberg, E. J. Benjamin, V. Bittner, L. T. Braun, D. C. Goff Jr, S. Havas, D. R. Labarthe, M. C. Limacher, D. M. Lloyd-Jones, et al. ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research Circulation, September 29, 2009; 120(13): 1296 - 1336. [Full Text] [PDF]

				N. R. Poulter, J. E. Dobson, P. S. Sever, B. Dahlof, H. Wedel, N. R.C. Campbell, and on behalf of the ASCOT Investigators Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial). J. Am. Coll. Cardiol., September 22, 2009; 54(13): 1154 - 1161. [Abstract] [Full Text] [PDF]

				C. Pitsavos, D.B. Panagiotakos, K.D. Tambalis, C. Chrysohoou, L.S. Sidossis, J. Skoumas, and C. Stefanadis Resistance exercise plus to aerobic activities is associated with better lipids' profile among healthy individuals: the ATTICA study QJM, September 1, 2009; 102(9): 609 - 616. [Abstract] [Full Text] [PDF]

				N. Vastesaeger, S. Xu, D. Aletaha, E. W. St Clair, and J. S. Smolen A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis Rheumatology, September 1, 2009; 48(9): 1114 - 1121. [Abstract] [Full Text] [PDF]

				F F Faletra, C Klersy, I D'Angeli, M Penco, V Procaccini, E Pasotti, A Marcolongo, G B Pedrazzini, S De Castro, M Scappaticci, et al. Relation between coronary atherosclerotic plaques and traditional risk factors in people with no history of cardiovascular disease undergoing multi-detector computed coronary angiography Heart, August 1, 2009; 95(15): 1265 - 1272. [Abstract] [Full Text] [PDF]

				P. G. Steg Heart rate management in coronary artery disease: the CLARIFY registry Eur. Heart J. Suppl., August 1, 2009; 11(suppl_D): D13 - D18. [Abstract] [Full Text] [PDF]

				K. Asplund, J. Karvanen, S. Giampaoli, P. Jousilahti, M. Niemela, G. Broda, G. Cesana, J. Dallongeville, P. Ducimetriere, A. Evans, et al. Relative Risks for Stroke by Age, Sex, and Population Based on Follow-Up of 18 European Populations in the MORGAM Project Stroke, July 1, 2009; 40(7): 2319 - 2326. [Abstract] [Full Text] [PDF]

				P. M. Nilsson, P. Boutouyrie, and S. Laurent Vascular Aging: A Tale of EVA and ADAM in Cardiovascular Risk Assessment and Prevention Hypertension, July 1, 2009; 54(1): 3 - 10. [Full Text] [PDF]

				M. J. Pencina, R. B. D'Agostino Sr, M. G. Larson, J. M. Massaro, and R. S. Vasan Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study Circulation, June 23, 2009; 119(24): 3078 - 3084. [Abstract] [Full Text] [PDF]

				A. El-Menyar, H. Amin, I. Rashdan, K. Souliman, D. Deleu, K. Saadat, W. Al Mahmeed, S. Bakir, A. Wasif, A. Ben Brek, et al. Ankle-Brachial Index and Extent of Atherosclerosis in Patients From the Middle East (the AGATHA-ME Study): A Cross-Sectional Multicenter Study Angiology, June 1, 2009; 60(3): 329 - 334. [Abstract] [PDF]

				E. Ketola, T. Laatikainen, and E. Vartiainen Evaluating risk for cardiovascular diseases--vain or value? How do different cardiovascular risk scores act in real life Eur J Public Health, May 29, 2009; (2009) ckp070v1. [Abstract] [Full Text] [PDF]

				M. Ravera, G. Noberasco, M. Re, A. Filippi, A. M. Gallina, U. Weiss, R. Cannavo, G. Ravera, C. Cricelli, and G. Deferrari Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1528 - 1533. [Abstract] [Full Text] [PDF]

				C K Chow, R Joshi, D S Celermajer, A Patel, and B C Neal Recalibration of a Framingham risk equation for a rural population in India J Epidemiol Community Health, May 1, 2009; 63(5): 379 - 385. [Abstract] [Full Text] [PDF]

				A. Patel Cardiovascular risk: who should we treat, and how much should we stratify? Heart, May 1, 2009; 95(10): 783 - 784. [Full Text] [PDF]

				P. Van der Niepen, A. Woestenburg, H. Brie, S. Vancayzeele, K. MacDonald, K. Denhaerynck, C. Lee, C. Hermans, and I. Abraham Effectiveness of Valsartan for Treatment of Hypertension: Patient Profiling and Hierarchical Modeling of Determinants and Outcomes (the PREVIEW Study) Ann. Pharmacother., May 1, 2009; 43(5): 849 - 861. [Abstract] [Full Text] [PDF]

				J. Leal, A. M. Gray, and P. M. Clarke Development of life-expectancy tables for people with type 2 diabetes Eur. Heart J., April 1, 2009; 30(7): 834 - 839. [Abstract] [Full Text] [PDF]

				P. B. Gorelick Challenges of Designing Trials for the Primary Prevention of Stroke Stroke, March 1, 2009; 40(3_suppl_1): S82 - S84. [Abstract] [Full Text] [PDF]

				A. D. Hingorani, T. Shah, J. P. Casas, S. E. Humphries, and P. J. Talmud C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target? Clin. Chem., February 1, 2009; 55(2): 239 - 255. [Abstract] [Full Text] [PDF]

				A J Kerr, J Broad, S Wells, T Riddell, and R Jackson Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart, January 15, 2009; 95(2): 125 - 129. [Abstract] [Full Text] [PDF]

				T. H. Stea, M. Wandel, M. A. Mansoor, S. Uglem, and W. Frolich BMI, lipid profile, physical fitness and smoking habits of young male adults and the association with parental education Eur J Public Health, January 1, 2009; 19(1): 46 - 51. [Abstract] [Full Text] [PDF]

				L. C. Gormsen, B. Nellemann, L. P. Sorensen, M. D. Jensen, J. S. Christiansen, and S. Nielsen Impact of body composition on very-low-density lipoprotein-triglycerides kinetics Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E165 - E173. [Abstract] [Full Text] [PDF]

				A. Rosengren, J. Perk, and J. Dallongeville CHAPTER 12 Prevention of Cardiovascular Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				S. E. Kjeldsen, T. A. Aksnes, R. H. Fagard, and G. Mancia CHAPTER 13 Hypertension ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				L. Alves and A. Azevedo Hypercholesterolemia, eligibility for lipid-lowering therapy and therapeutic success: population-based study in a Portuguese urban population Eur. J. Endocrinol., December 1, 2008; 159(6): 755 - 760. [Abstract] [Full Text] [PDF]

				M. King, C. Walker, G. Levy, C. Bottomley, P. Royston, S. Weich, J. A. Bellon-Saameno, B. Moreno, I. Svab, D. Rotar, et al. Development and Validation of an International Risk Prediction Algorithm for Episodes of Major Depression in General Practice Attendees: The PredictD Study Arch Gen Psychiatry, December 1, 2008; 65(12): 1368 - 1376. [Abstract] [Full Text] [PDF]

				B. J. Wells, A. Jain, S. Arrigain, C. Yu, W. A. Rosenkrans Jr., and M. W. Kattan Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes Diabetes Care, December 1, 2008; 31(12): 2301 - 2306. [Abstract] [Full Text] [PDF]

				J. L. Rosenzweig, E. Ferrannini, S. M. Grundy, S. M. Haffner, R. J. Heine, E. S. Horton, and R. Kawamori Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3671 - 3689. [Abstract] [Full Text] [PDF]

				J. Cederholm, K. Eeg-Olofsson, B. Eliasson, B. Zethelius, P. M. Nilsson, S. Gudbjornsdottir, and on behalf of the Swedish National Diabetes Registe Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register Diabetes Care, October 1, 2008; 31(10): 2038 - 2043. [Abstract] [Full Text] [PDF]

				T. M. Reynolds, A. Mardani, P. J. Twomey, and A. S. Wierzbicki Targeted versus global approaches to the management of hypercholesterolaemia Perspectives in Public Health, September 1, 2008; 128(5): 248 - 254. [Abstract] [PDF]

				E. J. Heffernan, J. D. Dodd, and D. E. Malone Cardiac Multidetector CT: Technical and Diagnostic Evaluation with Evidence-based Practice Techniques Radiology, August 1, 2008; 248(2): 366 - 377. [Abstract] [Full Text] [PDF]

				R. Ferrari, C. Ceconi, and G. Guardigli Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction Eur. Heart J. Suppl., August 1, 2008; 10(suppl_F): F7 - F10. [Abstract] [Full Text] [PDF]

				P. W.F. Wilson, S. R. Bozeman, T. M. Burton, D. C. Hoaglin, R. Ben-Joseph, and C. L. Pashos Prediction of First Events of Coronary Heart Disease and Stroke With Consideration of Adiposity Circulation, July 8, 2008; 118(2): 124 - 130. [Abstract] [Full Text] [PDF]

				P. Raggi, M. C. Gongora, A. Gopal, T. Q. Callister, M. Budoff, and L. J. Shaw Coronary artery calcium to predict all-cause mortality in elderly men and women. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 17 - 23. [Abstract] [Full Text] [PDF]

				T. Christiaens Cardiovascular risk tables BMJ, June 28, 2008; 336(7659): 1445 - 1446. [Full Text] [PDF]

				V. Barrios, C. Escobar, and R. Echarri Concomitance of Cardiovascular Comorbidities in the Hypertensive Population: Not Only in the United States Arch Intern Med, June 23, 2008; 168(12): 1350 - 1351. [Full Text] [PDF]

				J. P. Greving, E. Buskens, H. Koffijberg, and A. Algra Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk Circulation, June 3, 2008; 117(22): 2875 - 2883. [Abstract] [Full Text] [PDF]

				J.-P. Despres, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose, J. Rodes-Cabau, O. F. Bertrand, and P. Poirier Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1039 - 1049. [Abstract] [Full Text] [PDF]

				J. Muller-Nordhorn, S. Binting, S. Roll, and S. N. Willich An update on regional variation in cardiovascular mortality within Europe Eur. Heart J., May 2, 2008; 29(10): 1316 - 1326. [Abstract] [Full Text] [PDF]

				D. B. Panagiotakos, C. Pitsavos, C. Chrysohoou, and C. Stefanadis Hierarchical Analysis of Cardiovascular Risk Factors in Relation to the Development of Acute Coronary Syndromes, in Different Parts of Greece: The CARDIO2000 Study Angiology, May 1, 2008; 59(2): 156 - 165. [Abstract] [PDF]

				S Graff-Iversen, R Selmer, and M-L Lochen Rose angina predicts 23-year coronary heart disease mortality in women and men aged 40-49 years Heart, April 1, 2008; 94(4): 482 - 486. [Abstract] [Full Text] [PDF]

				V. Stangl, V. Witzel, G. Baumann, and K. Stangl Current diagnostic concepts to detect coronary artery disease in women Eur. Heart J., March 2, 2008; 29(6): 707 - 717. [Abstract] [Full Text] [PDF]

				R. B. D'Agostino Sr, R. S. Vasan, M. J. Pencina, P. A. Wolf, M. Cobain, J. M. Massaro, and W. B. Kannel General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study Circulation, February 12, 2008; 117(6): 743 - 753. [Abstract] [Full Text] [PDF]

				Y. M. Smulders, A. Thijs, and J. W. Twisk New cardiovascular risk determinants do exist and are clinically useful Eur. Heart J., February 2, 2008; 29(4): 436 - 440. [Abstract] [Full Text] [PDF]

				N. I. Parikh, M. J. Pencina, T. J. Wang, E. J. Benjamin, K. J. Lanier, D. Levy, R. B. D'Agostino Sr, W. B. Kannel, and R. S. Vasan A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study Ann Intern Med, January 15, 2008; 148(2): 102 - 110. [Abstract] [Full Text] [PDF]

				E. Ingelsson, M. J. Pencina, R. B. D'Agostino, and R. S. Vasan Utility of Different Lipid Measures to Predict Coronary Heart Disease Reply JAMA, January 2, 2008; 299(1): 36 - 36. [Full Text] [PDF]

				S. Hallan, B. Astor, S. Romundstad, K. Aasarod, K. Kvenild, and J. Coresh Association of Kidney Function and Albuminuria With Cardiovascular Mortality in Older vs Younger Individuals: The HUNT II Study Arch Intern Med, December 10, 2007; 167(22): 2490 - 2496. [Abstract] [Full Text] [PDF]

				J. C. Geller, S. Cassens, M. Brosz, U. Keil, J. Bernarding, S. Kropf, R. A. Bierwirth, B. Lippmann-Grob, H.-P. Schultheiss, K. Schluter, et al. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study Eur. Heart J., December 2, 2007; 28(24): 3051 - 3058. [Abstract] [Full Text] [PDF]

				T. van der Weijden, B. van Steenkiste, H.E.J.H. Stoffers, D.R.M. Timmermans, and R. Grol Primary Prevention of Cardiovascular Diseases in General Practice: Mismatch between Cardiovascular Risk and Patients' Risk Perceptions Med Decis Making, December 1, 2007; 27(6): 754 - 761. [Abstract] [PDF]

				Authors/Task Force Members, I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) Eur. Heart J., October 1, 2007; 28(19): 2375 - 2414. [Full Text] [PDF]

				K. de Leeuw, R. Graaff, R. de Vries, R. P. Dullaart, A. J. Smit, C. G. Kallenberg, and M. Bijl Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus Rheumatology, October 1, 2007; 46(10): 1551 - 1556. [Abstract] [Full Text] [PDF]

				C. Strom Moller, B. Zethelius, J. Sundstrom, and L. Lind Persistent ischaemic ECG abnormalities on repeated ECG examination have important prognostic value for cardiovascular disease beyond established risk factors: a population-based study in middle-aged men with up to 32 years of follow-up Heart, September 1, 2007; 93(9): 1104 - 1110. [Abstract] [Full Text] [PDF]

				K. Fox, J. S. Borer, A. J. Camm, N. Danchin, R. Ferrari, J. L. Lopez Sendon, P. G. Steg, J.-C. Tardif, L. Tavazzi, M. Tendera, et al. Resting Heart Rate in Cardiovascular Disease J. Am. Coll. Cardiol., August 28, 2007; 50(9): 823 - 830. [Abstract] [Full Text] [PDF]

				E. Ingelsson, E. J. Schaefer, J. H. Contois, J. R. McNamara, L. Sullivan, M. J. Keyes, M. J. Pencina, C. Schoonmaker, P. W. F. Wilson, R. B. D'Agostino, et al. Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women JAMA, August 15, 2007; 298(7): 776 - 785. [Abstract] [Full Text] [PDF]

				P. Collins, G. Rosano, C. Casey, C. Daly, M. Gambacciani, P. Hadji, R. Kaaja, T. Mikkola, S. Palacios, R. Preston, et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists Eur. Heart J., August 2, 2007; 28(16): 2028 - 2040. [Abstract] [Full Text] [PDF]

				B. Norrving, P. Wester, K. S. Sunnerhagen, A. Terent, A. Sohlberg, F. Berggren, P.-O. Wester, K. Asplund, for the Stroke Guidelines Working Group,, and National Board of Health and Welfare, Stockholm, S Beyond Conventional Stroke Guidelines: Setting Priorities Stroke, July 1, 2007; 38(7): 2185 - 2190. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF]

				M. H. Olsen, T. W. Hansen, M. K. Christensen, F. Gustafsson, S. Rasmussen, K. Wachtell, H. Ibsen, C. Torp-Pedersen, and P. R. Hildebrandt N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population Eur. Heart J., June 1, 2007; 28(11): 1374 - 1381. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]

				R. L. Coleman, R. J. Stevens, R. Retnakaran, and R. R. Holman Framingham, SCORE, and DECODE Risk Equations Do Not Provide Reliable Cardiovascular Risk Estimates in Type 2 Diabetes Diabetes Care, May 1, 2007; 30(5): 1292 - 1293. [Full Text] [PDF]

				D. Wood The concept of doctor targets based on quality guidelines: focus on blood pressure Eur. Heart J. Suppl., May 1, 2007; 9(suppl_B): B29 - B36. [Abstract] [Full Text] [PDF]

				M. J. Holzmann, N. Hammar, S. Ahnve, T. Nordqvist, K. Pehrsson, and T. Ivert Renal insufficiency and long-term mortality and incidence of myocardial infarction in patients undergoing coronary artery bypass grafting Eur. Heart J., April 1, 2007; 28(7): 865 - 871. [Abstract] [Full Text] [PDF]

				J. H. Revkin, C. L. Shear, H. G. Pouleur, S. W. Ryder, and D. G. Orloff Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future Pharmacol. Rev., March 1, 2007; 59(1): 40 - 53. [Abstract] [Full Text] [PDF]

				Asia Pacific Cohort Studies Collaboration Cardiovascular risk prediction tools for populations in Asia J Epidemiol Community Health, February 1, 2007; 61(2): 115 - 121. [Abstract] [Full Text] [PDF]

				P. Greenland, R. O. Bonow, B. H. Brundage, M. J. Budoff, M. J. Eisenberg, S. M. Grundy, M. S. Lauer, W. S. Post, P. Raggi, R. F. Redberg, et al. ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain: A Report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) Developed in Collaboration With the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography J. Am. Coll. Cardiol., January 23, 2007; 49(3): 378 - 402. [Full Text] [PDF]

				Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]

				S. J. L. Bakker, R. T. Gansevoort, and D. de Zeeuw Metabolic syndrome: a fata morgana? Nephrol. Dial. Transplant., January 1, 2007; 22(1): 15 - 20. [Full Text] [PDF]

				P Brindle, A Beswick, T Fahey, and S Ebrahim Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review Heart, December 1, 2006; 92(12): 1752 - 1759. [Abstract] [Full Text] [PDF]

				J S Jurgensen The value of risk scores Heart, December 1, 2006; 92(12): 1713 - 1714. [Abstract] [Full Text] [PDF]

				Y. Wu, X. Liu, X. Li, Y. Li, L. Zhao, Z. Chen, Y. Li, X. Rao, B. Zhou, R. Detrano, et al. Estimation of 10-Year Risk of Fatal and Nonfatal Ischemic Cardiovascular Diseases in Chinese Adults Circulation, November 21, 2006; 114(21): 2217 - 2225. [Abstract] [Full Text] [PDF]

				K De Leeuw, B Freire, A J Smit, H Bootsma, C G Kallenberg, and M Bijl Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus Lupus, October 1, 2006; 15(10): 675 - 682. [Abstract] [PDF]

				P. Paramsothy and R. Knopp Management of dyslipidaemias. Heart, October 1, 2006; 92(10): 1529 - 1534. [Full Text] [PDF]

				D.-H. Lee, K. Silventoinen, G. Hu, D. R. Jacobs Jr, P. Jousilahti, J. Sundvall, and J. Tuomilehto Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women Eur. Heart J., September 2, 2006; 27(18): 2170 - 2176. [Abstract] [Full Text] [PDF]

				D. M. Lloyd-Jones, K. Liu, L. Tian, and P. Greenland Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease Ann Intern Med, July 4, 2006; 145(1): 35 - 42. [Abstract] [Full Text] [PDF]

This Article Abstract FREE Full Text (PDF) E-letters: Submit a response Alert me when this article is cited Alert me when E-letters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (591) Request Permissions Disclaimer Google Scholar Articles by Conroy, R.M. Search for Related Content PubMed PubMed Citation Articles by Conroy, R.M. Social Bookmarking          What's this?

Online ISSN 1522-9645 - Print ISSN 0195-668x

Copyright © 2009 European Society of Cardiology

Oxford Journals Oxford University Press

• Site Map
• Privacy Policy
• Frequently Asked Questions

Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics